Peripheral artery disease (PAD) is associated with substantial morbidity, including a high
risk of cardiovascular and limb events and death. A growing body of evidence has …

Due to the pathophysiology of atherosclerosis, the management for coronary artery disease
and peripheral arterial disease (PAD) were considered homogenous, with therapies focused …

Lower extremity peripheral artery disease (PAD) is a malignant form of atherosclerosis
associated with a heightened risk of cardiovascular morbidity and mortality. 1 Many patients …

Peripheral artery disease (PAD) commonly refers to atherosclerotic narrowing of
noncoronary arteries, primarily those supplying the lower extremities. The risk factors for …

Although peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis, the
heightened cardiovascular risk in these patients has been consistently under-recognized by …

Atherosclerotic cardiovascular (CV) disease remains a major health concern affecting more
than 200 million adults worldwide, and lower extremity peripheral artery disease (PAD) is …

Peripheral artery disease (PAD) is the occlusion or narrowing of the arteries supplying the
lower extremities. Peripheral artery disease has been estimated to affect approximately 240 …

Comprehensive medical and non-medical management of PAD patients is crucial to
improving patient outcomes, mitigating symptoms, and reducing the risk of MACE and …

This Commentary highlights the under-recognized prevalence and heavy burden of
peripheral artery disease (PAD) and its important role as a harbinger of complications of …

Aims: To ascertain the effectiveness of medical therapy for reducing risk in peripheral artery
disease (PAD) and to model the potential impact of combining multiple efficacious …